1. Nanocrystalline Hydroxyapatite Loaded with Resveratrol in Colloidal Suspension Improves Viability, Metabolic Activity and Mitochondrial Potential in Human Adipose-Derived Mesenchymal Stromal Stem Cells (hASCs)
    Krzysztof Marycz et al, 2019, Polymers CrossRef
  2. MiR-223 as a Regulator and Therapeutic Target in Liver Diseases
    Jiarong Gu et al, 2022, Frontiers in Immunology CrossRef
  3. The role of NLRP3 inflammasome in hepatocellular carcinoma
    Huijie Zhao et al, 2023, Frontiers in Pharmacology CrossRef
  4. MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies
    Gulcin Tezcan et al, 2019, Frontiers in Pharmacology CrossRef
  5. NLRP3 Depletion Fails to Mitigate Inflammation but Restores Diminished Phagocytosis in BV-2 Cells After In Vitro Hypoxia
    Isabelle Schölwer et al, 2020, Molecular Neurobiology CrossRef
  6. Inflammation and Inflammasomes: Pros and Cons in Tumorigenesis
    Liliana R. Balahura et al, 2020, Journal of Immunology Research CrossRef
  7. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma
    Leonardo Lorente, 2018, World Journal of Gastroenterology CrossRef
  8. hsa-miR-17-5p: A Possible Predictor of Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir ± Ribavirin Therapy Efficacy in Hepatitis C Infection
    Zehra Öksüz et al, 2022, Current Microbiology CrossRef
  9. MASLD and aspartame: are new studies in the horizon?
    Consolato M. Sergi, 2023, Frontiers in Medicine CrossRef
  10. The Inhibitory Effect of NLRP3 Deficiency in Hepatocellular Carcinoma SK-Hep1 Cells
    Wonhyeok Choi et al, 2021, Microbiology and Biotechnology Letters CrossRef
  11. The intervention effect of Aitongxiao prescription on primary liver cancer rats was evaluated based on high-throughput miRNA sequencing and bioinformatics analysis
    Lijing Xu et al, 2023, Frontiers in Oncology CrossRef
  12. Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer
    Sonia Missiroli et al, 2021, Cancers CrossRef
  13. The Role of Inflammasome in Cancers and Potential Therapeutic Targets
    Pooya Farhangnia et al, 2023, Handbook of Cancer and Immunology CrossRef
  14. Targeting Inflammasome Activation in COVID-19: Delivery of RNA Interference-Based Therapeutic Molecules
    Lealem Gedefaw et al, 2021, Biomedicines CrossRef
  15. Sevoflurane-induced POCD-associated exosomes delivered miR-584-5p regulates the growth of human microglia HMC3 cells through targeting BDNF
    Jia Zhao et al, 2022, Aging CrossRef
  16. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment
    Chen Xue et al, 2022, Frontiers in Immunology CrossRef
  17. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver Diseases
    Congjian Shi et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
  18. MicroRNA-550a-3-5p controls the brain metastasis of lung cancer by directly targeting YAP1
    Liang Wei et al, 2021, Cancer Cell International CrossRef
  19. Hsa-miR-223-3p participates in the process of anthracycline-induced cardiomyocyte damage by regulating NFIA gene
    Xiao Han et al, 2023, Open Medicine CrossRef
  20. The effect of miR-223-3p on endothelial cells in coronary artery disease
    Boxin Zhao et al, 2024, In Vitro Cellular & Developmental Biology - Animal CrossRef

  21. Anisodamine Suppressed the Growth of Hepatocellular Carcinoma Cells, Induced Apoptosis and Regulated the Levels of Inflammatory Factors by Inhibiting NLRP3 Inflammasome Activation


    Ping Li et al, 2020, Drug Design, Development and Therapy CrossRef
  22. MiR-223-3p attenuates the migration and invasion of NSCLC cells by regulating NLRP3
    Shasha Zhu et al, 2022, Frontiers in Oncology CrossRef